Lotus Pharmaceutical Co Ltd

Price Chart

Risk-Adjusted Performance

Lotus Pharmaceutical Co Ltd (1795) Price Performance

Lotus Pharmaceutical Co Ltd (1795) trades on TW in TWD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at TWD234.50, down 0.64% from the previous close.

Over the past year, 1795 has traded between a low of TWD186.00 and a high of TWD363.00. The stock has gained 13.6% over this period. It is currently 35.4% below its 52-week high.

Lotus Pharmaceutical Co Ltd has a market capitalization of $62.02B, with a price-to-earnings ratio of 13.07 and a dividend yield of 1.09%.

About Lotus Pharmaceutical Co Ltd

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Compare Lotus Pharmaceutical Co Ltd

Side-by-side comparison against top Healthcare peers.